Validation and optimisation of a commercial cell-based assay for detection of nodo-paranodal antibodies
Pathology · 2026
DOI: 10.1016/j.pathol.2025.06.009 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Pathology, 2026. Verfasst von Julian Leto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Royal Prince Alfred Hospital, Pathology East, NSW Health Pathology, Camperdown, NSW, Australia. Hauptthemen laut MEDLINE: Autoantibodies, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, Royal Prince Alfred Hospital, Pathology East, NSW Health Pathology, Camperdown, NSW, Australia.
- Department of Neurology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
- Department of Clinical Immunology, Royal Prince Alfred Hospital, Pathology East, NSW Health Pathology, Camperdown, NSW, Australia; Institute of Academic Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia…
Zitieren
APA
Leto, J., Spies, J., Tran, L., Luo, I., Stoyanov, A., Bradhurst, P., & Urriola, N. (2026). Validation and optimisation of a commercial cell-based assay for detection of nodo-paranodal antibodies. Pathology. https://doi.org/10.1016/j.pathol.2025.06.009
Vancouver
Leto J, Spies J, Tran L, Luo I, Stoyanov A, Bradhurst P, et al. Validation and optimisation of a commercial cell-based assay for detection of nodo-paranodal antibodies. Pathology. 2026. doi:10.1016/j.pathol.2025.06.009
BibTeX
@article{Leto2026,
author = {Leto, Julian and Spies, Judith and Tran, Linda and Luo, Irene and Stoyanov, Alex and Bradhurst, Peter and Urriola, Nicolás},
title = {Validation and optimisation of a commercial cell-based assay for detection of nodo-paranodal antibodies},
journal = {Pathology},
year = {2026},
doi = {10.1016/j.pathol.2025.06.009}
}
EUVIMED